Castleark Management LLC Neurocrine Biosciences Inc Transaction History

Castleark Management LLC

$2.41 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$106.72 - $127.06 $88,577 - $105,459	830 Added 1.57%	53,600 $6.4 Million
Q3 2022 Nov 15, 2022	SELL	$92.03 - $107.81 $113,196 - $132,606	-1,230 Reduced 2.28%	52,770 $5.61 Million
Q2 2022 Aug 16, 2022	BUY	$75.79 - $100.07 $663,920 - $876,613	8,760 Added 19.36%	54,000 $5.26 Million
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $3.28 Million - $4.29 Million	45,240 New	45,240 $4.24 Million
Q4 2021 Feb 16, 2022	SELL	$79.65 - $106.22 $111,908 - $149,239	-1,405 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $155,436 - $211,935	-1,775 Reduced 55.82%	1,405 $137,000
Q3 2020 Nov 16, 2020	SELL	$96.16 - $135.15 $1.08 Million - $1.52 Million	-11,250 Reduced 77.96%	3,180 $306,000
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $3.7 Million - $5.68 Million	-43,542 Reduced 75.11%	14,430 $1.76 Million
Q1 2020 May 13, 2020	SELL	$75.11 - $113.76 $2.7 Million - $4.09 Million	-35,995 Reduced 38.31%	57,972 $5.02 Million
Q4 2019 Feb 14, 2020	SELL	$86.8 - $118.57 $873,034 - $1.19 Million	-10,058 Reduced 9.67%	93,967 $10.1 Million
Q3 2019 Nov 15, 2019	BUY	$83.82 - $101.5 $8.72 Million - $10.6 Million	104,025 New	104,025 $9.37 Million
Q1 2019 May 14, 2019	SELL	$69.31 - $91.53 $1.09 Million - $1.44 Million	-15,775 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$68.32 - $124.36 $2.11 Million - $3.84 Million	-30,890 Reduced 66.2%	15,775 $1.13 Million
Q3 2018 Nov 15, 2018	BUY	$98.88 - $125.85 $414,801 - $527,940	4,195 Added 9.88%	46,665 $5.74 Million
Q2 2018 Aug 15, 2018	SELL	$75.3 - $105.99 $262,044 - $368,845	-3,480 Reduced 7.57%	42,470 $4.17 Million
Q1 2018 May 15, 2018	BUY	$75.88 - $92.43 $1.24 Million - $1.51 Million	16,330 Added 55.13%	45,950 $3.81 Million
Q4 2017 Feb 15, 2018	BUY	$58.53 - $77.59 $1.73 Million - $2.3 Million	29,620	29,620 $2.3 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.94 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.36 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$703 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$351 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$254 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.

Account